Abstract:Drug repositioning, an important method of drug development, is utilized to discover investigational drugs beyond the originally approved indications, expand the application scope of drugs, and reduce the cost of drug development. With the emergence of increasingly drug-disease-related biological networks, the challenge still remains to effectively fuse biological entity data and accurately achieve drug-disease repositioning. This paper proposes a new drug repositioning method named EMPHCN based on enhanced message passing and hypergraph convolutional networks (HGCN). It firstly constructs the homogeneous multi-view information with multiple drug similarity features and then extracts the intra-domain embedding of drugs through the combination of HGCN and channel attention mechanism. Secondly, inter-domain information of known drug-disease associations is extracted by graph convolutional networks combining node and edge embedding (NEEGCN), and a heterogeneous network composed of drugs, proteins and diseases is built as an important auxiliary to enhance the inter-domain message passing of drugs and diseases. Besides, the intra-domain embedding of diseases is also extracted through HGCN. Ultimately, intra-domain and inter-domain embeddings of drugs and diseases are integrated as the final embedding for calculating the drug-disease correlation matrix. Through 10-fold cross-validation on some benchmark datasets, we find that the AUPR of EMPHCN reaches 0.593 (T1) and 0.526 (T2), respectively, and the AUC achieves 0.887 (T1) and 0.961 (T2) respectively, which shows that EMPHCN has an advantage over other state-of-the-art prediction methods. Concerning the new disease association prediction, the AUC of EMPHCN through the five-fold cross-validation reaches 0.806 (T1) and 0.845 (T2), which are 4.3% (T1) and 4.0% (T2) higher than the second best existing methods, respectively. In the case study, EMPHCN also achieves satisfactory results in real drug repositioning for breast carcinoma and Parkinson's disease.

A spatial hierarchical network learning framework for drug repositioning allowing interpretation from macro to micro scale

deepDR: a network-based deep learning approach to in silico drug repositioning

A general hypergraph learning algorithm for drug multi-task predictions in micro-to-macro biomedical networks

Computational Drug Repositioning Using Meta-Path-based Semantic Network Analysis.

A geometric deep learning framework for drug repositioning over heterogeneous information networks

Drug repositioning based on the heterogeneous information fusion graph convolutional network

Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity

Computational Drug Repositioning with Random Walk on a Heterogeneous Network

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

Predicting drug-disease associations by network embedding and biomedical data integration.

Drug Repositioning Method Based on Deep Neural Network

Drug Repurposing Therapeutics Prediction using Hierarchical Graph Neural Network.

Drug repositioning based on weighted local information augmented graph neural network

A weighted bilinear neural collaborative filtering approach for drug repositioning

DRONet: effectiveness-driven drug repositioning framework using network embedding and ranking learning

Spatial Graph Convolutions for Drug Discovery.

Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks

An Effective Multi-Task Learning Framework for Drug Repurposing Based on Graph Representation Learning.

Drug Repositioning Based on the Enhanced Message Passing and Hypergraph Convolutional Networks

Network-Based Approaches for Drug Repositioning.

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data